甘肃加快实施中医药传承创新工程

2018-04-28 赵丹 中国中医

近日,甘肃省发展改革委会同省卫生计生委组织召开了该省疑难病症诊治能力提升工程和中医药传承创新工程项目推进会。兰州大学第一医院、甘肃省人民医院、甘肃省中医院、甘肃中医药大学附属医院、天水市中医医院等5家医院分管领导及项目负责人参加。甘肃省发展改革委副主任曹天民主持会议

近日,甘肃省发展改革委会同省卫生计生委组织召开了该省疑难病症诊治能力提升工程和中医药传承创新工程项目推进会。兰州大学第一医院、甘肃省人民医院、甘肃省中医院、甘肃中医药大学附属医院、天水市中医医院等5家医院分管领导及项目负责人参加。甘肃省发展改革委副主任曹天民主持会议

会议要求,5家医院应抢抓时间,加快办理项目前期手续,推动项目早日开工建设,并依法合规做好建设工作。其中,负责中医药传承创新工程的3家医院要遵循中医药发展规律,紧紧围绕发挥中医药特色与优势,坚持加大投入与深化改革并举,坚持继承与创新结合,坚持加强内涵建设与能力提高融合,认真做好项目建设工作,确保完成建设任务,顺利实现发展目标。

中医药传承创新工程由国家发展改革委、国家中医药管理局联合组织,重点支持一定数量的省市中医医院(含中西医结合医院、民族医医院)和省级中医药科研机构(含民族医药科研机构)能力建设,全国共有99家医院被纳入项目储备库。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675583, encodeId=b0e516e5583f2, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Wed Jan 02 19:14:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796819, encodeId=d7aa1e96819db, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 13 03:14:00 CST 2018, time=2018-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285570, encodeId=d19e12855e08b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409510, encodeId=410d1409510d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=)]
    2019-01-02 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675583, encodeId=b0e516e5583f2, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Wed Jan 02 19:14:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796819, encodeId=d7aa1e96819db, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 13 03:14:00 CST 2018, time=2018-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285570, encodeId=d19e12855e08b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409510, encodeId=410d1409510d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675583, encodeId=b0e516e5583f2, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Wed Jan 02 19:14:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796819, encodeId=d7aa1e96819db, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 13 03:14:00 CST 2018, time=2018-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285570, encodeId=d19e12855e08b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409510, encodeId=410d1409510d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675583, encodeId=b0e516e5583f2, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Wed Jan 02 19:14:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796819, encodeId=d7aa1e96819db, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 13 03:14:00 CST 2018, time=2018-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285570, encodeId=d19e12855e08b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409510, encodeId=410d1409510d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 30 08:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=)]
    2018-04-30 cathymary

相关资讯

基药高出市场价,整改!这省卫计委发文了

甘肃省卫计委发文,解决基药价格高出市场价问题!

家庭医生新任务:送人就医

基层首诊、双向转诊如何能够更好落地?甘肃出新招:送医上门,送人就医!

甘肃将与巴西开展中医药领域合作

4月18日,甘肃省卫生计生委党组书记尚裕良在兰州市会见来访的巴西中医药学会会长方芳、巴西联邦药物监督委员会委员保罗·瓦兰达等一行,并就进一步加强甘肃省和巴西在中医药领域的交流合作进行座谈。

甘肃1亿元扶持医院薄弱学科

近日,甘肃省卫生部门印发《2018年县级医院薄弱学科建设实施方案》,确定了甘南州人民医院、卓尼县人民医院等19家县级综合医院作为薄弱学科建设项目实施单位。甘肃省财政厅共安排1亿元用于支持县级医院薄弱学科建设项目,对每个薄弱学科平均补助125万元,市县级财政对县级医院薄弱学科建设也将给予支持。

甘肃重点推行按病种付费 病种数量达500种

甘肃将逐年增加分级诊疗病种数量。

严禁设定创收指标 甘肃扩大公立医院薪酬制度改革试点

甘肃省政府办公厅近日印发《关于加快建立现代医院管理制度的实施意见》。《实施意见》明确了政府对医院监管职能。提出要规范医疗机构和医务人员诊疗行为,保障医疗质量安全,有效控制医疗费用的不合理增长。将全省医疗费用平均增幅控制在10%以内,对转诊率低的地区或医疗机构,可适当放宽费用增幅的控制。严禁公立医院举债建设和豪华装修甘肃省将建立综合监管制度,重点加强对各级各类医院医疗质量安全、医疗费用以及大处方、